Literature DB >> 19490049

Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy.

Cameron J Lacey1, Michael R Salzberg, Helene Roberts, Tom Trauer, Wendyl J D'Souza.   

Abstract

We aimed to determine the level of psychological distress in community-treated patients with epilepsy and to determine if this distress is associated with increased health service use. The Australian National prescription database was used to recruit patients with epilepsy onto the Tasmanian Epilepsy Register (TER). Psychological distress was measured using the K10 in the TER patients and compared to the Tasmanian population using the National Health Survey 2004-5. Of the 1,180 on the TER, 43 withdrew, 36 died, and 262 were excluded. Of 839 patients, 652 completed the K10 (78%). High-very high levels of psychological distress were observed in patients with epilepsy compared with the general population [odds ratio (OR) 2.14, 95% confidence interval (CI) 1.79-2.56]. Patients with high-very high psychological distress had increased attendance at general practitioners (p < 0.001), specialists (p = 0.02), and emergency departments (p = 0.004). Psychological distress is increased in community-treated patients with epilepsy compared to the general population, and is associated with increased health service use.

Entities:  

Mesh:

Year:  2009        PMID: 19490049     DOI: 10.1111/j.1528-1167.2009.02165.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

Review 1.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

2.  Comorbidity increases the risk of hospitalizations in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

Review 3.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

4.  A nurse-led self-management intervention for people who attend emergency departments with epilepsy: the patients' view.

Authors:  Adam J Noble; Myfanwy Morgan; Cheryl Virdi; Leone Ridsdale
Journal:  J Neurol       Date:  2012-11-16       Impact factor: 4.849

5.  Health Service Use among Individuals with Depression and Psychological Distress: A Population-Based Cohort Study in Ontario, Canada: Utilisation des services de santé par les personnes souffrant de dépression et de détresse psychologique : une étude de cohorte dans la population de l'Ontario, Canada.

Authors:  Maria Chiu; Farah E Saxena; Paul Kurdyak; Andrew S Wilton; Simone N Vigod
Journal:  Can J Psychiatry       Date:  2020-05-27       Impact factor: 4.356

Review 6.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

7.  Psychiatric comorbidity in patients with epilepsy: a population-based study.

Authors:  Mohamad Karouni; Subaneesan Arulthas; Pål G Larsson; Elisif Rytter; Svein I Johannessen; Cecilie Johannessen Landmark
Journal:  Eur J Clin Pharmacol       Date:  2010-07-29       Impact factor: 2.953

8.  Electroencephalogram abnormalities in panic disorder patients: a study of symptom characteristics and pathology.

Authors:  Karin Hayashi; Mariko Makino; Masahiro Hashizume; Koichi Nakano; Koji Tsuboi
Journal:  Biopsychosoc Med       Date:  2010-08-23

9.  Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol.

Authors:  Maree L Hackett; Nicholas S Glozier; Alexandra L Martiniuk; Stephen Jan; Craig S Anderson
Journal:  BMC Neurol       Date:  2011-01-09       Impact factor: 2.474

10.  Factors influencing participation in a vascular disease prevention lifestyle program among participants in a cluster randomized trial.

Authors:  Rachel A Laws; Mahnaz Fanaian; Upali W Jayasinghe; Suzanne McKenzie; Megan Passey; Gawaine Powell Davies; David Lyle; Mark F Harris
Journal:  BMC Health Serv Res       Date:  2013-05-31       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.